Imagen de Portada

The past, present and future of penile cancer in the Nordic countries. Results from NORDCAN

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Christian Arvei Moen, Axel Gerdtsson, Mikael Aagaard, Andreas Hopland, Peter Kirrander, Jakob Kristian Jakobsen
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	BJUI Compass
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Lymph node surgery after centralization of penile cancer care in Sweden: Extent of use and complications
por: Åsa Warnolf, et al.
Publicado: (2026)

Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
por: Alfred Honoré, et al.
Publicado: (2025)

Video‐endoscopic versus open inguinal lymphadenectomy: Long‐term oncological outcomes in penile cancer
por: Ranya Kumar, et al.
Publicado: (2026)

Glans tunnel‐based reconstruction with skin flap or lip mucosa graft for distal penile urethral strictures
por: Fuhao Ji, et al.
Publicado: (2025)

Shedding light on night‐time erections: Determining the feasibility of nocturnal erection detection with penile transdermal light reflection of haemoglobin
por: Evelien J. Trip, et al.
Publicado: (2024)

The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
por: Heikki Seikkula, et al.
Publicado: (2024)

Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025)

Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients
por: Antti Nummi, et al.
Publicado: (2025)

Perioperative factors influencing immediate and long‐term continence after robot‐assisted radical prostatectomy
por: Till Rostalski, et al.
Publicado: (2026)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
por: Serdar Turan, et al.
Publicado: (2025)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
por: Marcus Sondermann, et al.
Publicado: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
por: Alison Hiong, et al.
Publicado: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
por: Sophia M. Abusamra, et al.
Publicado: (2025)

Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
por: Markus Angerer, et al.
Publicado: (2026)

Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)

Alcohol consumption among patients diagnosed with genitourinary cancers
por: Aidan Weitzner, et al.
Publicado: (2025)

Patient experience of bladder cancer: A data linkage study
por: Snehadhar Shah, et al.
Publicado: (2024)

Penile cancer in French Guiana: Epidemiology, histopathology and clinical aspects
por: Khalil Chalhoub, et al.
Publicado: (2025)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
por: Ailene E. Corona, et al.
Publicado: (2026)

Hospital variation in the treatment of cT1a renal cancer
por: Cato Caroline Bresser, et al.
Publicado: (2026)

Urinary microbiota diversity and composition in patients with advanced renal cell cancer
por: Frederico Leal, et al.
Publicado: (2026)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
por: Nikhil Mayor, et al.
Publicado: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
por: Geneva Pantoja, et al.
Publicado: (2025)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
por: Liwu Guo, et al.
Publicado: (2024)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
por: Eric Margolis, et al.
Publicado: (2025)

Malignant upper urinary tract obstruction in cancer patients: A systematic review
por: Max Shah, et al.
Publicado: (2024)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
por: Katherina Y. Chen, et al.
Publicado: (2026)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
por: Yin Zhou, et al.
Publicado: (2024)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
por: Jonathon Dawson, et al.
Publicado: (2024)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
por: Liam Mannion, et al.
Publicado: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
por: Muhammad Haider, et al.
Publicado: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
por: Muhammad Imran, et al.
Publicado: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
por: Sandra Irenaeus, et al.
Publicado: (2025)